Proving what pharma media actually drives
Most pharma agencies can show you reach and frequency. Very few can show you what that investment actually changed in HCP behavior, patient engagement, or prescribing outcomes. We build media programs where every channel has a role and every dollar connects to a measurable result.
Trusted by
Deep vertical expertise
We work with pharmaceutical brands across therapeutic areas: oncology, immunology, rare disease, and consumer health. Compliance is built into everything we do, but it is not the headline. What sets our work apart is proving how media investment drives the outcomes your leadership team cares about: HCP engagement, patient action, and commercial results.
How we work in pharma
Full-funnel media architecture where disease awareness, HCP education, and patient engagement work as one connected system, not three separate workstreams with three separate dashboards
Structured testing that produces real learnings about what moves HCP and patient behavior, not just what generates compliant impressions at scale
Measurement that connects upper-funnel awareness to downstream commercial outcomes, proving how brand investment drives the results your leadership reviews, not just the metrics your media team tracks
Scenario planning that builds the evidence base for scaling investment, showing leadership exactly what increased spend produces before committing the budget
The hard problems in pharma
Proving media moves the needle
The gap between a digital impression and a prescription is wide and hard to measure. Most pharma media gets evaluated on reach and frequency because that is what is easy to report. We connect media investment to downstream commercial outcomes so you can see what your spend actually changed.
Reaching HCPs and patients after signal loss
Privacy restrictions and third-party cookie deprecation have reshaped audience targeting in pharma. We build contextual and first-party strategies that reach the right people without relying on data sources that are disappearing, or that create compliance risk.
Getting leadership to invest in the upper funnel
Pharma leadership is often skeptical of brand investment because the connection to commercial results is hard to prove. We build the measurement framework that makes that connection visible, so increasing awareness spend feels evidence-based, not aspirational.
Results in pharma
Trusted by pharma leaders
QRY acts like a direct extension of our team and they truly take the time to understand our business and where they can drive the best results. They’re quick to adjust and adopt new channels and overall help us to set a high bar with our media.
We’ve found the right partner. We really value their open communication and their willingness to jump in and work with us to continually hone our strategy.
The team is incredibly knowledgeable with a vast expertise across multiple facets. I feel as though at any moment, I can pick up the phone and talk through ideas, concerns, strategies, and so forth.
“QRY is constantly developing new strategies and new ideas for how we might be able to get better performance. Even in months we’ve not been able to increase our budget, they’ve worked with us to rethink how we can best redeploy our resources in really smart ways.”
Without QRY, revenue would flatline
Of all the external partners and agencies I’ve worked with, QRY stands out as the best..
Working with the QRY team has been a game-changer for our DTC business. They think proactively about our needs and manage our entire digital media strategy, not just the tactics. It’s what sets them apart.
Let's talk about pharma
Start with a strategy conversation. We will assess your current media program and outline what growth looks like in your vertical.